3-iodobenzylguanidine has been researched along with alpha-Galactosidase A Deficiency in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuocolo, A; Dell'Aversana, S; Imbriaco, M; Nappi, C; Pellegrino, T; Petretta, M; Pisani, A; Piscopo, V; Ponsiglione, A; Puglia, M; Riccio, E; Spinelli, L | 1 |
| Cuocolo, A; Gaudieri, V; Giugliano, G; Imbriaco, M; Nappi, C; Pisani, A; Riccio, E; Spinelli, L; Trimarco, B | 1 |
| Massalha, S; Slart, RHJA | 1 |
| Cuocolo, A; Giudice, CA; Imbriaco, M; Pellegrino, T; Pisani, A; Riccio, E; Salvatore, M; Spinelli, L; Trimarco, B | 1 |
| Aoki, T; Kozu, K; Miura, M; Ota, H; Sato, H; Shimokawa, H; Sugimura, K; Suzuki, H; Takanami, K; Takase, K; Tatebe, S; Yamamoto, S; Yaoita, N | 1 |
5 other study(ies) available for 3-iodobenzylguanidine and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cohort Studies; Fabry Disease; Female; Fibrosis; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Neurons; Sympathetic Nervous System | 2017 |
Focal reduction in left ventricular
Topics: 3-Iodobenzylguanidine; Adult; Fabry Disease; Female; Heart Ventricles; Humans; Male; Middle Aged; Radiopharmaceuticals; Sympathetic Nervous System; Systole; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Young Adult | 2021 |
Anderson-Fabry disease: Worthy to in-SPECT the nerves?
Topics: 3-Iodobenzylguanidine; Fabry Disease; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Tomography, Emission-Computed, Single-Photon | 2021 |
Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diastole; Fabry Disease; Female; Heart; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sympathetic Nervous System; Ventricular Function, Left | 2016 |
Focal Reduction in Cardiac
Topics: 3-Iodobenzylguanidine; Fabry Disease; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Myocardium; Radionuclide Imaging | 2016 |